Seha Virtual Hospital (SVH) in Riyadh, Saudi Arabia, has selected Lunit’s AI-powered cancer screening solutions for its AI evaluation and clinical integration project.

The collaboration aims to add to the ‘transformation’ of healthcare across Saudi Arabia in line with the Saudi Vision 2030 strategy.

The AI cancer screening solutions, Lunit INSIGHT CXR for chest X-ray image analysis and Lunit INSIGHT MMG for mammography analysis, will undergo validation and integration at SVH.

Following evaluation, they are expected to be implemented at more than 170 medical sites across Saudi Arabia as part of a national cancer and tuberculosis screening programme.

SVH was established last year and is claimed to be the world’s largest virtual hospital.

It supports 170 hospitals and provides medical services to 480,000 patients each year.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The integration of Lunit’s solutions is intended to increase the effectiveness of cancer screening and improve patient care in Saudi Arabia.

Lunit CEO Brandon Suh said: “We are delighted to partner with Seha Virtual Hospital and contribute to the transformation of cancer diagnosis in Saudi Arabia.

“Given that Saudi Arabia boasts the largest medical market in the Gulf Cooperation Council, our highly promising partnership allows us to tap into this growing market.

“Through this collaboration, we aim to bring our innovative AI-powered solutions to healthcare providers throughout the Middle East, ultimately improving patient outcomes and making a significant impact on the fight against cancer.”

Lunit was founded in 2013 and is based in Seoul, South Korea.

The company’s collaboration with SVH follows previous partnerships with the BreastScreen New South Wales programme in Australia last year and the Capio St Göran Hospital in Sweden last month.

Earlier this year, it partnered with the National Cancer Center Hospital East (NCCHE) in Japan to evaluate and validate its AI pathology solution for the analysis of tissue data.